Johnson Johnson Hopes Dethrone AbbVie’s Growth Driver
Two pharma giants are wighting for a leadership position in immunology. This piece explains why Johnson Johnson hopes...
If you want minimal turnover, this guide highlights index funds with the least turnover and how to assess them for your portfolio.
27,312 articlesTwo pharma giants are wighting for a leadership position in immunology. This piece explains why Johnson Johnson hopes...
As AI excitement cools, investors parse the shift from trade short-term bets to a lasting investment decade. BlackRoc...
As AI fuels data growth, Silicon Motion Technology stands out in the memory controller niche. This article breaks dow...
NexaTech Holdings, a $40 billion market-cap company, raised its revenue guidance on stronger-than-expected demand, si...
After the latest earnings, investors are weighing growth prospects, margins, and valuation for Domino's. This guide b...
Explore how Permian Resources could navigate 2025 earnings, debt reduction, and growth opportunities. Learn who benef...
The DOJ settlement with Live Nation aims to boost competition and transparency in ticketing, but analysts warn it may...
When a company CEO sells thousands of shares, investors take notice. This guide breaks down what National Vision's so...
Keel Infrastructure led the session with a notable move as investors weighed its pivot to AI data centers. This piece...
As Hovnanian prepares to report Q2 2026 earnings, investors will scrutinize backlog, margins, and guidance. This anal...
NVIDIA moves to secure critical design software by taking a $2 billion stake in Synopsys, signaling a deeper alignmen...
A leading analyst signals more upside for CVS Health as Medicare-related momentum builds. Learn the key drivers, risk...